NCT05103579

Brief Summary

MindMics earbuds is a new technology designed enhance an individual's quality of life by continuously monitoring the heart rate, stress, and blood pressure allowing patients to make decisions regarding their health. MindMics has a working prototype of the ear buds which will perform all the conventional tasks of earbuds (listen to music, etc.), but, in addition, will measure heart rate, stress, blood pressure. The earbuds capture the sounds made by the various cardiac structures pulsing and moving blood. The sound is caused by the acceleration and deceleration of blood and the turbulence developed during rapid blood flow.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 24, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 2, 2021

Completed
Last Updated

November 2, 2021

Status Verified

November 1, 2021

Enrollment Period

10 months

First QC Date

October 18, 2021

Last Update Submit

November 1, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Performance of the MindMics device for detecting Atrial Fibrillation based on inter-beat intervals

    Sensitivity and specificity for detecting Atrial Fibrillation using inter-beat intervals and statistical measures based on inter-beat intervals

    30 minutes

Study Arms (2)

Patients with AFib

Patients with AFib

Device: MindMics

Normal patients

Normal patients without AFib

Device: MindMics

Interventions

MindMicsDEVICE

Patients rhythms was recorded using MindMics device

Normal patientsPatients with AFib

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Approximately 25 patients will be recruited for group 1 from inpatient or outpatient office visits. Approximately 25 patients will be recruited for group 2 prior to direct-current cardioversion allowing collection of data from before and after cardioversion to document differences in recordings during sinus rhythm after having successful cardioversion from atrial fibrillation.

You may qualify if:

  • AFib

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prisma Health

Sumter, South Carolina, 29150, United States

Location

MeSH Terms

Conditions

Atrial FibrillationArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2021

First Posted

November 2, 2021

Study Start

March 24, 2020

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

November 2, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations